Press Releases

INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, announced the signing of a non-binding memorandum of understanding (MOU) with Colombia's Ministry of...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced a new Memorandum of Understanding (MoU) to make up to 110 million doses of the Moderna COVID-19 vaccine available to the African Union. The Company is...

Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, announced an exclusive partnership with Stallergenes Greer, a global healthcare company specializing in allergen immunotherapy (AIT), for the development of a new connected drug...

FUJIFILM Diosynth Biotechnologies (FDB) and Istari Oncology announced that they have entered into an agreement for the manufacturing of Istari Oncology’s viral immunotherapy, PVSRIPO, currently being investigated for the treatment of solid tumors. FUJIFILM Diosynth Biotechnologies is a leading Contract...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced Swissmedic has authorized a booster dose of Spikevax, the Company’s vaccine against COVID-19, at the 50 µg dose level in particularly vulnerable individuals 12 years of...

Catalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced a $230 million expansion project to add three further commercial-scale viral...

The launch edition of MedicalTech Innovation Forum, as Messe Frankfurt India’s first-ever hybrid conference was held at Visakhapatnam in October 2021. Experts from the healthcare industry discussed the need for optimum infrastructure, regulatory framework and innovation in the Indian...